NYSE: MD

Pediatrix Medical Group Inc Stock Forecast, Predictions & Price Target

The consensus among 4 Wall Street analysts covering (NYSE: MD) stock is to Hold MD stock.

Out of 4 analysts, 0 (0%) are recommending MD as a Strong Buy, 0 (0%) are recommending MD as a Buy, 4 (100%) are recommending MD as a Hold, 0 (0%) are recommending MD as a Sell, and 0 (0%) are recommending MD as a Strong Sell.

If you're new to stock investing, here's how to buy Pediatrix Medical Group stock.

(NYSE: MD) Pediatrix Medical Group's forecast annual revenue growth rate of 3.18% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.25%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.1%.

Pediatrix Medical Group's revenue in 2024 is $1,994,640,000.On average, 6 Wall Street analysts forecast MD's revenue for 2024 to be $170,374,185,246, with the lowest MD revenue forecast at $169,300,607,788, and the highest MD revenue forecast at $171,191,944,725. On average, 6 Wall Street analysts forecast MD's revenue for 2025 to be $175,877,005,794, with the lowest MD revenue forecast at $173,966,320,572, and the highest MD revenue forecast at $177,549,959,477.

In 2026, MD is forecast to generate $185,489,654,481 in revenue, with the lowest revenue forecast at $185,173,856,818 and the highest revenue forecast at $186,021,143,463.

According to 4 Wall Street analysts that have issued a 1 year MD price target, the average MD price target is $9.38, with the highest MD stock price forecast at $10.00 and the lowest MD stock price forecast at $9.00.

On average, Wall Street analysts predict that Pediatrix Medical Group's share price could reach $9.38 by Mar 6, 2025. The average Pediatrix Medical Group stock price prediction forecasts a potential upside of 3.82% from the current MD share price of $9.03.

(NYSE: MD) forecast ROE is N/A, which is considered weak.